ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI

Radioimmunoassay, Cannabinoid(s)

HOFFMANN-LA ROCHE, INC.

The following data is part of a premarket notification filed by Hoffmann-la Roche, Inc. with the FDA for Abuscreen Radioimmunoassay For Cannabi.

Pre-market Notification Details

Device IDK820391
510k NumberK820391
Device Name:ABUSCREEN RADIOIMMUNOASSAY FOR CANNABI
ClassificationRadioimmunoassay, Cannabinoid(s)
Applicant HOFFMANN-LA ROCHE, INC. 803 N. Front St. Suite 3 Mchenry,  IL  60050
Product CodeLAT  
CFR Regulation Number862.3870 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1982-02-10
Decision Date1982-03-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.